Novel Regimen Boosts Survival for Recurrent Platinum-Resistant Ovarian Cancer

Novel Regimen Boosts Survival for Recurrent Platinum-Resistant Ovarian Cancer

SAN JUAN, PUERTO RICO — A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with a significant improvement in overall survival (OS), according to a ROSELLA trial update. Adding the glucocorticoid receptor antagonist relacorilant (Lifyorli) to nab-paclitaxel improved median overall survival (OS) by 4 months versus nab-paclitaxel alone. The regimen…

Read More

Your Weekly Horoscope: April 12–18, 2026

Your weekly horoscope is here. Comms heat up and hasten up as Mercury zips into Aries, heralding fresh ideas and heated exchanges. Tempers may flare in this volatile yet enthusiastic sign, considering seven planets are flying through Aries by Wednesday; even La Luna joins the fray as she resets anew on Friday. Since Aries is…

Read More